Tolmetin and salicylate therapy in acute rheumatic fever Comparison of clinical efficacy and side effects
dc.authorid | 3304 | en_US |
dc.authorid | 113274 | en_US |
dc.contributor.author | Karademir, Selmin | |
dc.contributor.author | Oğuz, Deniz | |
dc.contributor.author | Şenocak, Filiz | |
dc.contributor.author | Öcal, Burhan | |
dc.contributor.author | Karakurt, Cemşit | |
dc.contributor.author | Çabuk, Feryal | |
dc.date.accessioned | 2018-01-30T05:19:13Z | |
dc.date.available | 2018-01-30T05:19:13Z | |
dc.date.issued | 2003 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | Pediatrics International (2003) 45 , 676–679. | en_US |
dc.description.abstract | Background : The arthritis of rheumatic fever is very responsive to treatment with salicylates, but there aremany adverse reactions, especially hepatotoxicity, due to aspirin (acetylsalicylic acid) therapy. These side-effects change the course and duration of rheumatic fever. Other non-steroidal anti-inflammatory drugs maybe equally effective, although no reports are available. Methods : We studied 72 patients with rheumatic fever who were admitted to Dr Sami Ulus Children’s Hospitalbetween 1995 and 1999. Twenty patients with arthritis were treated with tolmetin (25 mg/kg per day; group I)and 52 patients with arthritis and/or mild carditis were put on aspirin therapy (75–100 mg/kg per day) for 4–6weeks (group II). Arthritis had disappeared at the same time in both the aspirin and tolmetin groups (P = 0.675). Results : The erythrocyte sedimentation rates of patients upon admission, at the first week and at the end oftherapy were not different in the two groups (P > 0.05). No adverse effect of tolmetin therapy was observed,whereas side-effects of salicylate were observed in 19 patients (36.5%) in the aspirin group. Hepatotoxicity,gastric irritation and salicylism were found in 16, four and three patients, respectively. Renal toxicity andReye syndrome were not demonstrated. Because of these side-effects of aspirin, therapy had to be stopped for10–20 days and the duration of hospitalization in this group was lengthened unnecessarily. Conclusion : Tolmetin was safe and effective treatment for arthritic rheumatic fever patients without carditis.Tolmetin can be used particularly in patients who cannot tolerate aspirin. | en_US |
dc.identifier.citation | Karademir, S., Oğuz, D., Şenocak, F., Öcal, B., Karakurt, C., Cabuk, F. (2009). Tolmetin and salicylate therapy in acute rheumatic fever Comparison of clinical efficacy and side effects. Pediatrics International. | en_US |
dc.identifier.doi | 10.1111/j.1442-200X.2003.01801.x | en_US |
dc.identifier.endpage | 0 | en_US |
dc.identifier.issue | 0 | en_US |
dc.identifier.startpage | 0 | en_US |
dc.identifier.uri | http://onlinelibrary.wiley.com/doi/10.1111/j.1442-200X.2003.01801.x/epdf | |
dc.identifier.uri | https://hdl.handle.net/11616/8028 | |
dc.identifier.volume | 0 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pediatrics International | en_US |
dc.relation.ispartof | Pediatrics International | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Aspirin | en_US |
dc.subject | Rheumatic fever | en_US |
dc.subject | Tolmetin | en_US |
dc.title | Tolmetin and salicylate therapy in acute rheumatic fever Comparison of clinical efficacy and side effects | en_US |
dc.type | Article | en_US |